These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35643926)

  • 1. Pharmacokinetic and pharmacodynamic considerations of antibiotics and antifungals in liver transplantation recipients.
    Morales Junior R; Telles JP; Kwiatkowski SY; Juodinis VD; de Souza DC; Santos SRCJ
    Liver Transpl; 2023 Jan; 29(1):91-102. PubMed ID: 35643926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants.
    Roberts JK; Stockmann C; Constance JE; Stiers J; Spigarelli MG; Ward RM; Sherwin CM
    Clin Pharmacokinet; 2014 Jul; 53(7):581-610. PubMed ID: 24871768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics.
    Singh J; Burr B; Stringham D; Arrieta A
    Paediatr Drugs; 2001; 3(10):733-61. PubMed ID: 11706924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of bacterial and fungal infections in end stage liver disease and liver transplantation: Current options and future directions.
    Righi E
    World J Gastroenterol; 2018 Oct; 24(38):4311-4329. PubMed ID: 30344417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous Antibiotic and Antifungal Agent Pharmacokinetic-Pharmacodynamic Dosing in Adults with Severe Burn Injury.
    Cota JM; FakhriRavari A; Rowan MP; Chung KK; Murray CK; Akers KS
    Clin Ther; 2016 Sep; 38(9):2016-31. PubMed ID: 27586127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug-resistant bacterial infections after liver transplantation: an ever-growing challenge.
    Santoro-Lopes G; de Gouvêa EF
    World J Gastroenterol; 2014 May; 20(20):6201-10. PubMed ID: 24876740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock.
    De Paepe P; Belpaire FM; Buylaert WA
    Clin Pharmacokinet; 2002; 41(14):1135-51. PubMed ID: 12405864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and Pharmacodynamics of Antimicrobial Agents in Burn Patients.
    Pruskowski KA
    Surg Infect (Larchmt); 2021 Feb; 22(1):77-82. PubMed ID: 33164665
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic considerations in antimicrobial therapy for sepsis.
    Fujii M; Karumai T; Yamamoto R; Kobayashi E; Ogawa K; Tounai M; Lipman J; Hayashi Y
    Expert Opin Drug Metab Toxicol; 2020 May; 16(5):415-430. PubMed ID: 32238005
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetics of antifungal agents in neonates and young infants.
    Regazzi M; Billaud EM; Lefeuvre S; Stronati M
    Curr Med Chem; 2012; 19(27):4621-32. PubMed ID: 22876899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Infectious complications after liver transplantation].
    Moncorge C; Matmar M
    Ann Radiol (Paris); 1994; 37(5):383-5. PubMed ID: 7993025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of antifungals in children and their clinical implications.
    Stockmann C; Constance JE; Roberts JK; Olson J; Doby EH; Ampofo K; Stiers J; Spigarelli MG; Sherwin CM
    Clin Pharmacokinet; 2014 May; 53(5):429-54. PubMed ID: 24595533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy in elderly transplant recipients: a guide to clinically significant drug interactions.
    Kuypers DR
    Drugs Aging; 2009; 26(9):715-37. PubMed ID: 19728747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor-derived infections among Chinese donation after cardiac death liver recipients.
    Ye QF; Zhou W; Wan QQ
    World J Gastroenterol; 2017 Aug; 23(31):5809-5816. PubMed ID: 28883707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Impacts and Outcomes With Possible Donor-Derived Infection in Infected Donor Liver Transplantation: A Single-Center Retrospective Study in China.
    Tong L; Hu XG; Huang F; Huang SW; Li LF; Tang ZX; Yao JY; Xu JH; Zhu YP; Chen YH; He XS; Guan XD; Cai C
    J Infect Dis; 2020 Mar; 221(Suppl 2):S164-S173. PubMed ID: 32176783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis and forecast for multidrug-resistant Acinetobacter baumannii Infections among liver transplant recipients.
    Guo W; Sheng J; Gu Y; Xing TH; Peng ZH; Zhong L
    Transplant Proc; 2014 Jun; 46(5):1448-52. PubMed ID: 24935312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease. An update.
    Morgan DJ; McLean AJ
    Clin Pharmacokinet; 1995 Nov; 29(5):370-91. PubMed ID: 8582120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Postoperative intensive care of biliary atresia patients treated with living donor liver transplantation].
    Deng YH; Guo CB; Zhang MM; Li YC
    Zhonghua Er Ke Za Zhi; 2011 Jan; 49(1):21-6. PubMed ID: 21429307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantation.
    Hellinger WC; Bonatti H; Yao JD; Alvarez S; Brumble LM; Keating MR; Mendez JC; Kramer DJ; Dickson RC; Harnois DM; Spivey JR; Hughes CB; Nguyen JH; Steers JL
    Liver Transpl; 2005 Jun; 11(6):656-62. PubMed ID: 15915482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Use of Etanercept for Graft-Versus-Host Disease After Liver Transplant: the Importance of Broad Spectrum Infective Prophylaxis.
    Boscolo A; Menin E; Zelaschi B; Albertoni L; Zanus G; Baratto F
    Exp Clin Transplant; 2020 Feb; 18(1):123-127. PubMed ID: 29619911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.